As drug prices climb, possible reforms face “heavy” opposition

“This post from the American Medical Association I included encouraging discussing the problems of drugs being too expensive for many.  Allowing importation of identical drugs from the developed countries, after the US FDA has approved the methods of the foreign production, has been discussed for many years in the US Senate. I remember watching a debate live on C-Span several years ago. Senator John McCain was one of the two authors of the legislation. I am sure the text is still available from Sen. McCain’s office. “Bill Chesnut, MD

As drug prices climb, possible reforms face “heavy” opposition

The Kaiser Health News (10/20, Appleby) reports that “a jump in the number of new expensive drugs hitting the market” has “helped make prescription drugs the fastest-growing segment of the nation’s health care tab.” Two common proposals for reducing drug prices, allowing Medicare to negotiate drug prices and allowing re-importation of drugs, face “heavy” opposition in Congress and are not “likely to gain much traction.” The article also evaluates other proposals, such as disclosing the costs of drug development, capping consumer copayments, and tying payments to the drug’s result.

AMA WIRE 10.20.15